Join
Live feed
·
PRReleasevia Quantisnow
AbbVie Inc. logo
Xilio Therapeutics Inc. logo

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

ByQuantisnow·Wall Street's wire, on your screen.
ABBV· AbbVie Inc.XLO· Xilio Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABBV (AbbVie Inc.), XLO (Xilio Therapeutics Inc.) and more on Quantisnow.